Daré Bioscience
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Daré Bioscience's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 72% to $2,807,885. The net income dropped to -$30,161,391 and profit margin reached -1074%. Total operating expenses were $33,609,402.
Profit Margin
| 2014 | 80K | -23.34M | -29177.5% |
|---|---|---|---|
| 2015 | 0 | -39.59M | |
| 2016 | 766K | -39.30M | -5131.2% |
| 2017 | 0 | -11.50M | |
| 2018 | 0 | -26.97M | |
| 2019 | 0 | -14.26M | |
| 2020 | 0 | -27.40M | |
| 2021 | 0 | -38.32M | |
| 2022 | 10M | 406.80M | 4068.02% |
| 2023 | 2.80M | -30.16M | -1074.17% |
DARE Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 2.80M | 10M | 0 | 0 | 0 | 0 | 0 | 766K | 0 | 80K |
Cost of revenue | 38.36K | 47.61K | 26.41K | 43.22K | 11.13K | 2.44K | 0 | 400K | 192K | 0 |
Gross profit | 2.76M | 9.95M | -26.41K | -43.22K | -11.13K | -2.44K | 0 | 366K | -192K | 80K |
Operating exp. | ||||||||||
Research and development | 21.53M | 30.04M | 30.61M | 20.76M | 8.54M | 6.41M | 984.74K | 27.56M | 25.94M | 11.77M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 33.60M | 41.38M | 39.06M | 27.40M | 14.34M | 11.69M | 3.68M | 37.92M | 37.17M | 20.35M |
Operating income | -30.83M | -31.38M | -39.06M | -27.40M | -14.34M | -16.88M | -11.18M | -37.15M | -37.17M | -20.27M |
Other income (expenses), net | 678.48K | 437.75K | 372.40K | 1.51K | 81.05K | 143.49K | -322.62K | -2.15M | -2.42M | -3.06M |
Income before tax | -30.16M | -30.94M | -38.69M | -27.40M | -14.26M | -16.73M | -11.50M | -39.30M | -39.59M | -23.34M |
Income tax expense | 0 | -437.75M | -369.88K | -163.07K | 0 | 10.23M | -7.16M | 86K | 10K | 1.08M |
Net income | -30.16M | 406.80M | -38.32M | -27.40M | -14.26M | -26.97M | -11.50M | -39.30M | -39.59M | -23.34M |
Earnings per share | ||||||||||
Basic EPS | -4.15 | 4.81 | -0.63 | -10.93 | -0.92 | -2.51 | -3.56 | -14.18 | -15.57 | -16.04 |
Diluted EPS | -4.15 | 4.81 | -0.63 | -10.93 | -0.92 | -2.51 | -3.56 | -14.18 | -15.57 | -16.04 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |